Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 9(62), 2018

DOI: 10.1128/aac.00359-18

Links

Tools

Export citation

Search in Google Scholar

Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

The increasing incidence of multidrug-resistant Mycobacterium tuberculosis strains and the very few drugs available for treatment are promoting the discovery and development of new molecules that could help in the control of this disease. Bacteriocin AS-48 is an antibacterial peptide produced by Enterococcus faecalis and is active against several Gram-positive bacteria.